Intermittent Hypoxia-Hyperoxia and Oxidative Stress in Developing Human Airway Smooth Muscle

Area of Science:

• Cellular and Molecular Biology
• Neonatal Physiology
• Respiratory Medicine

Background:

• Neonatal supplemental oxygen therapy can lead to intermittent hypoxia and hyperoxia.
• Hyperoxia is linked to bronchopulmonary dysplasia and asthma, while hypoxia is vital for in utero lung development.
• Understanding oxygen's impact on airway mitochondria is key for therapeutic strategies.

Purpose of the Study:

• To investigate the effects of different oxygen concentrations (hypoxia, normoxia, hyperoxia, and intermittent hypoxia-hyperoxia) on mitochondria in human fetal airway smooth muscle cells.
• To assess the role of the antioxidant N-acetylcysteine in mitigating oxygen-induced mitochondrial changes.

Main Methods:

• Human fetal airway smooth muscle cells were exposed to 5% O2 (hypoxia), 21% O2 (normoxia), 40% O2 (hyperoxia), or cycling between 5% and 40% O2.
• Mitochondrial reactive oxygen species production, morphology, and respiration were measured.
• Experiments were conducted with and without the antioxidant N-acetylcysteine.

Main Results:

• Oxygen exposure differentially affected mitochondrial structure and function in developing airway smooth muscle cells.
• Intermittent hypoxia-hyperoxia, hypoxia, and hyperoxia decreased mitochondrial branching and branch length, particularly with antioxidant presence.
• Hypoxia reduced mitochondrial respiration, while N-acetylcysteine increased respiration under normoxic and cycling conditions.

Conclusions:

• Developing airway smooth muscle exhibits distinct mitochondrial responses to varying oxygen conditions.
• Oxygen cycling impacts mitochondrial morphology similarly to sustained hypoxia or hyperoxia.
• Maintaining a balance between oxidative damage and antioxidant defenses is essential for healthy airway development.